pubrio
Alto Neuroscience logo

Alto Neuroscience

Public
altoneuroscience.com
生物技術81 employeesFounded 2019🇺🇸 美國

Alto Neuroscience is redefining psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective medicines, helping patients get better faster. Alto's Precision Psychiatry Platform™ measures biomarkers like EEG and wearable data, behavioral patterns, genetics, and other factors to match patients with the treatment they are most likely to respond to. Our approach matches the right patient with the right Alto drug based on AI-derived brain biomarkers, redefining psychiatry at a time when the world needs it most.

成立年份
2019
員工
81
行業
生物技術
公司類型
Public Company
股票
nasdaq: ANRO
總部
🇺🇸Mountain View, California (+1)
專長
製藥產業生物技術醫療保健

擴張情報

全新 · Pubrio 獨家

我們正在追蹤 Alto Neuroscience 的市場擴張

全球擴張

即時
階段
探索中投入中進入中營運中
值得了解

關於 Alto Neuroscience 的常見問題

關於 Alto Neuroscience 業務、市場及增長訊號的快速解答。

Alto Neuroscience is redefining psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective medicines, helping patients get better faster. Alto's Precision Psychiatry Platform™ measures biomarkers like EEG and wearable data, behavioral patterns, genetics, and other factors to match patients with the treatment they are most likely to respond to. Our approach matches the right patient with the right Alto drug based on AI-derived brain biomarkers, redefining psychiatry at a time when the world needs it most.

立即展開你的旅程

可以先用平台,也可以先聊聊

自行使用 Pubrio,或讓我們的團隊協助研究、挖掘潛在客戶,甚至串接資料。

Start Journey Image
pubrio

Pubrio 將 50+ 個在地來源的商業、人才與意圖數據全球化整合,讓 AI 與營收團隊掌握完整市場視野。

© 2026 Pubrio。版權所有。